News Daily News More Evidence Links Breast Arterial Calcification and CVD Risk L.A. McKeown March 15, 2022
News Conference News BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years Caitlin E. Cox March 02, 2022
News Daily News Even Less-Severe COVID-19 Can Have Long-term CV Effects Caitlin E. Cox February 10, 2022
News Daily News Myocarditis After COVID Vaccination Is Rare, Resolves Quickly, Studies Confirm L.A. McKeown January 25, 2022
News Daily News Hearts, Lungs, Kidneys: Mild-to-Moderate COVID-19 Leaves a Mark Caitlin E. Cox January 14, 2022
News Daily News AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD Caitlin E. Cox December 28, 2021
News Daily News Another Win for Guided P2Y12 Therapy in ACS: Meta-analysis Yael L. Maxwell December 24, 2021
News Daily News Still No Edge for Bivalirudin in VALIDATE-SWEDEHEART’s STEMI Patients Shelley Wood December 22, 2021
News Daily News Correction Issued for Controversial Study Linking COVID-19 Vaccines to ACS Risk Todd Neale December 22, 2021
News Daily News The ‘Black Box’ of Asymptomatic, Stable, Ischemic CAD Treated With PCI Caitlin E. Cox December 09, 2021
Presentation Controversies and Advances 2021 Pathways for Inflammation in Athero-thrombosis Focus on Inflammasome Presenter: P. K. Shah December 03, 2021
News Daily News Questions Raised About Study Linking mRNA Vaccines to Increased ACS Risk Todd Neale December 03, 2021
News Daily News Shock in COVID-19: Types, Triggers, and Treatments Differ, but Outlook Is Grim Caitlin E. Cox November 24, 2021
News Conference News AHA 2021 No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials Todd Neale November 15, 2021
News Conference News TCT 2021 DCBs in Coronaries? Some Good News, but More Work Needed L.A. McKeown November 06, 2021
News Conference News TCT 2021 More DAPT Duration Data, More Calls to Tailor to Individual Patients Shelley Wood November 05, 2021